- Previous Close
27.10 - Open
27.68 - Bid 26.88 x --
- Ask 27.14 x --
- Day's Range
26.79 - 27.92 - 52 Week Range
22.80 - 66.17 - Volume
533 - Avg. Volume
2,345 - Market Cap (intraday)
46.931B - Beta (5Y Monthly) 0.67
- PE Ratio (TTM)
-- - EPS (TTM)
-30.11 - Earnings Date Jan 1, 2025 - Jan 5, 2025
- Forward Dividend & Yield 1.89 (6.98%)
- Ex-Dividend Date Nov 14, 2024
- 1y Target Est
--
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.
www.walgreensbootsalliance.com193,000
Full Time Employees
August 31
Fiscal Year Ends
Healthcare
Sector
Pharmaceutical Retailers
Industry
Recent News: WGBA34.SA
View MoreCompare To: WGBA34.SA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: WGBA34.SA
View MoreValuation Measures
Market Cap
46.92B
Enterprise Value
225.89B
Trailing P/E
--
Forward P/E
5.50
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.05
Price/Book (mrq)
0.75
Enterprise Value/Revenue
0.25
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-5.85%
Return on Assets (ttm)
0.59%
Return on Equity (ttm)
-75.97%
Revenue (ttm)
147.66B
Net Income Avi to Common (ttm)
-8.64B
Diluted EPS (ttm)
-30.11
Balance Sheet and Cash Flow
Total Cash (mrq)
3.11B
Total Debt/Equity (mrq)
277.90
Levered Free Cash Flow (ttm)
2.73B